Top Markets
Coin of the day
Neovasc Inc. Neovasc Inc.

Neovasc Inc.

NVCN
Rangering i aksjer #17840
Neovasc Inc. is a medical technology firm specializing in the design,... Neovasc Inc. is a medical technology firm specializing in the design, production, and global distribution of cardiovascular devices, particularly across European markets and beyond. Its primary offerings include the Tiara system, developed for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer, used to address chronic, debilitating chest pain known as refractory angina. Established in 2000, the company, which maintains its headquarters in Richmond, Canada, was formerly named Medical Ventures Corp. before adopting its current identity, Neovasc Inc., in July 2008.
Aksjekurs
$29.82
Sist synkronisert: 2023-04-11
Markedsverdi
$223.68M
Endring (1 dag)
1.21%
Endring (1 år)
0.00%
Land
CA
Handel Neovasc Inc. (NVCN)

Kategori

EPS for Neovasc Inc. (NVCN)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Neovasc Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Neovasc Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter